Predictors of Multidrug-Resistant Tuberculosis (MDR-TB) in Sudan

被引:17
|
作者
Ali, Monadil H. [1 ,2 ]
Alrasheedy, Alian A. [3 ]
Hassali, Mohamed Azmi [1 ]
Kibuule, Dan [4 ]
Godman, Brian [1 ,5 ,6 ,7 ]
机构
[1] Univ Sains Malaysia, Sch Pharmaceut Sci, Discipline Social & Adm Pharm, Minden 11800, Malaysia
[2] Northern Border Univ, Coll Pharm, Dept Clin Pharm, Rafha 91911, Saudi Arabia
[3] Qassim Univ, Unaizah Coll Pharm, Qasim 51911, Saudi Arabia
[4] Univ Namibia, Fac Hlth Sci, Sch Pharm, 340 Mandume Ndemufayo Ave Pioneers Pk, Windhoek 13301, Namibia
[5] Karolinska Univ Hosp Huddinge, Karolinska Inst, Div Clin Pharmacol, Dept Lab Med, SE-14186 Stockholm, Sweden
[6] Univ Strathclyde, Strathclyde Inst Pharm & Biomed Sci, Glasgow G4 0RE, Lanark, Scotland
[7] Sefako Makgatho Hlth Sci Univ, Sch Pharm, ZA-0204 Pretoria, South Africa
来源
ANTIBIOTICS-BASEL | 2019年 / 8卷 / 03期
关键词
MDR-TB; Predictors; Sudan; Tuberculosis; RISK-FACTORS; DRUG-RESISTANCE; PATTERN; STATE;
D O I
10.3390/antibiotics8030090
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Multidrug-resistant tuberculosis (MDR-TB) is a global public health threat and burden on the health system. This is especially the case in high tuberculosis (TB) prevalence countries, such as Sudan. Consequently, this study aimed to ascertain the predictors of MDR-TB in Sudan to provide future guidance. An unmatched case-control study to assess the predictors of MDR-TB infections among the Sudanese population was conducted from August 2017 to January 2018 at Abu-Anga referral hospital. Patients' data was gathered from patients' cards and via interviews. A structured pre-validated questionnaire was used to gather pertinent information, which included sociodemographic characteristics and other relevant clinical data. Univariate and multivariate logistic regression analysis was employed to determine the predictors of MDR-TB infection. 76 of the 183 patients interviewed (41.5%) had MDR-TB cases. The independent predictors for MDR-TB were living in rural areas [adjusted odds ratio (aOR) = 3.1 (95% confidence interval (CI): 1.2-8.2)], treatment failure [aOR = 56.9 (10.2-319.2)], and smoking [(aOR = 4 (1.2-13.2)], whereas other sociodemographic factors did not predict MDR-TB. In conclusion, the study showed that a history of smoking, living in rural areas, and a previous treatment failure were the predictors of MDR-TB in Sudan. The latter factors are most likely due to issues that are related to access and adherence to treatment and lifestyle. The existence of any of these factors among newly diagnosed TB patients should alert clinicians for the screening of MDR-TB. The implementation of directly observed treatment (DOT) and health education are crucial in stopping the spread of MDR-TB in Sudan.
引用
收藏
页数:11
相关论文
共 50 条
  • [1] Determinants of multidrug-resistant tuberculosis (MDR-TB) in Belarus
    Skrahina, Alena
    Hurevich, Henadz
    Zalutskaya, Aksana
    Sahalchyk, Evgeni
    Astrauko, Andrei
    Hoffner, Sven
    Rusovich, Valiantsin
    Dadu, Andrei
    de Colombani, Pierpaolo
    Dara, Masoud
    Van Gemert, Wayne
    Zignol, Matteo
    EUROPEAN RESPIRATORY JOURNAL, 2012, 40
  • [2] Assessment of multidrug-resistant tuberculosis (MDR-TB) treatment outcomes in Sudan; findings and implications
    Ali, Monadil H.
    Alrasheedy, Alian A.
    Kibuule, Dan
    Godman, Brian
    Hassali, Mohamed Azmi
    Ali, Hamdan Mustafa Hamdan
    EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2019, 17 (11) : 927 - 937
  • [3] Multidrug-resistant tuberculosis (MDR-TB): epidemiology, prevention and treatment
    Ormerod, LP
    BRITISH MEDICAL BULLETIN, 2005, 73-74 : 17 - 24
  • [4] New Drugs for the Treatment of Multidrug-resistant Tuberculosis (MDR-TB)
    Schaberg, T.
    Otto-Knapp, R.
    Bauer, T.
    PNEUMOLOGIE, 2015, 69 (05): : 282 - 286
  • [5] Multidrug-resistant tuberculosis (MDR-TB) in a BMT recipient.
    Altclas, JD
    Adrian, LO
    Salgueira, CC
    Brennan, VI
    Di Martino, A
    Ritacco, V
    Palmero, D
    BLOOD, 2003, 102 (11) : 445B - 445B
  • [6] Targeting multidrug-resistant tuberculosis (MDR-TB) by therapeutic vaccines
    Satria A. Prabowo
    Matthias I. Gröschel
    Ed D. L. Schmidt
    Alena Skrahina
    Traian Mihaescu
    Serap Hastürk
    Rotislav Mitrofanov
    Edita Pimkina
    Ildikó Visontai
    Bouke de Jong
    John L. Stanford
    Père-Joan Cardona
    Stefan H. E. Kaufmann
    Tjip S. van der Werf
    Medical Microbiology and Immunology, 2013, 202 : 95 - 104
  • [7] Disadvantage and the experience of treatment for multidrug-resistant tuberculosis (MDR-TB)
    Taylor, Holly A.
    Dowdy, David W.
    Searle, Alexandra R.
    Stennett, Andrea L.
    Dukhanin, Vadim
    Zwerling, Alice A.
    Merritt, Maria W.
    SSM-QUALITATIVE RESEARCH IN HEALTH, 2022, 2
  • [8] Targeting multidrug-resistant tuberculosis (MDR-TB) by therapeutic vaccines
    Prabowo, Satria A.
    Groeschel, Matthias I.
    Schmidt, Ed D. L.
    Skrahina, Alena
    Mihaescu, Traian
    Hasturk, Serap
    Mitrofanov, Rotislav
    Pimkina, Edita
    Visontai, Ildik
    de Jong, Bouke
    Stanford, John L.
    Cardona, Pere-Joan
    Kaufmann, Stefan H. E.
    Werf, Tjip S. van der
    MEDICAL MICROBIOLOGY AND IMMUNOLOGY, 2013, 202 (02) : 95 - 104
  • [9] New projects for rapid diagnosis of multidrug-resistant tuberculosis (MDR-TB)
    Desikan, Prabha
    NATIONAL MEDICAL JOURNAL OF INDIA, 2008, 21 (04): : 211 - 212
  • [10] The global risk of dying from multidrug-resistant tuberculosis (MDR-TB)
    Brondi, Luciana
    Falzon, Dennis
    Sismanidis, Charalambos
    Glaziou, Philippe
    Zignol, Matteo
    Floyd, Katherine
    Campbell, Harry
    Nair, Harish
    EUROPEAN RESPIRATORY JOURNAL, 2014, 44